The trading price of Intensity Therapeutics Inc (NASDAQ:INTS) closed lower on Friday, May 23, and closing at $0.32, -0.82% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $0.3014 and $0.33. In examining the 52-week price action we see that the stock hit a 52-week high of $5.10 and a 52-week low of $0.29. Over the past month, the stock has lost -44.31% in value.
Intensity Therapeutics Inc, whose market valuation is $5.80 million at the time of this writing, is expected to release its quarterly earnings report on 2025-May-12. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest INTS has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that INTS’s price is currently -35.37% off the SMA20 and -75.54% off the SMA50. The RSI metric on the 14-day chart is currently showing 15.52, and weekly volatility stands at 7.19%. When measured over the past 30 days, the indicator reaches 6.43%. Intensity Therapeutics Inc (NASDAQ:INTS)’s beta value is currently sitting at 4.40, while the Average True Range indicator is currently displaying 0.10. With analysts defining $5-$5 as the low and high price targets, we arrive at a consensus price target of $5 for the trailing 12-month period. The current price is about -1462.5% off the estimated low and -1462.5% off the forecast high, based on this estimate. Investors will be thrilled if INTS’s share price rises to $5, which is the median consensus price. At that level, INTS’s share price would be -1462.5% below current price.
To see how Intensity Therapeutics Inc stock has been performing in comparison to its peers in the industry, here are the numbers: INTS stock’s performance was -0.82% in the latest trading, and -93.70% in the past year.
An evaluation of the daily trading volume of Intensity Therapeutics Inc (NASDAQ:INTS) indicates that the 3-month average is 253.49K. However, this figure has increased over the past 10 days to an average of 0.8.
Currently, records show that 15.26 million of the company’s shares remain outstanding. The insiders hold 45.56% of outstanding shares, whereas institutions hold 14.16%. The stats also highlight that short interest as of 2025-04-30, stood at 0.17 million shares, resulting in a short ratio of 0.62 at that time. From this, we can conclude that short interest is 162.00 of the company’s total outstanding shares. It is noteworthy that short shares in April were up slightly from the previous month’s figure, which was 57293.0. However, since the stock’s price has seen -82.10% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
